NCT00157560View on ClinicalTrials.gov

Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

83

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

November 30, 2006

Study Completion Date

July 31, 2005

Conditions

Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer

Interventions

DRUG

Chemotherapy, multiple agents

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

Massachusetts General Hospital

OTHER